Daniel Shoemaker Net Worth & Insider Trades
Daniel Shoemaker - Chief Scientific Officer, Fate Therapeutics Inc
What is Daniel Shoemaker's Net Worth?
The current estimated net worth of Fate Therapeutics Inc's Chief Scientific Officer, Daniel Shoemaker, is estimated to be about $6.93M . Daniel Shoemaker owns about 73,020 units of Fate Therapeutics Inc common stock. In the last 7 years at Fate Therapeutics Inc, Daniel Shoemaker has sold an estimated value of $6.71M worth.
What is Daniel Shoemaker's Past Insider Trading?
Daniel Shoemaker's largest purchase order was 25,000 units , worth over $72.5K on January 2, 2020. Daniel Shoemaker's largest sale order was 25,000 units , worth over $2.04M on March 9, 2021. In total, Daniel Shoemaker has made about 19 transactions over 7 years of their time at Fate Therapeutics Inc. Daniel Shoemaker usually trades in January, with the busiest year in 2020 and 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Daniel Shoemaker
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Daniel Shoemaker's Salary in 2020?
As Chief Scientific Officer of Fate Therapeutics Inc, Daniel Shoemaker has a total base salary of $390,000 . Daniel Shoemaker received compensation valued at about $2,459,097 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of stock awards of $549,750 , option awards of $1,324,347 , other earnings, plans or compensations of $195,000 , and
What is Daniel Shoemaker's' Mailing Address?
- Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 CA
Fate Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. Scott Wolchko | 2020 | $570,000 | - | $1,451,340 | $3,222,577 | $356,250 | - | $5,600,167 |
| J. Scott Wolchko | 2019 | $540,000 | - | $4,137,500 | $5,732,955 | $310,500 | - | $10,720,955 |
| J. Scott Wolchko | 2018 | $516,000 | - | - | $2,756,998 | $258,000 | - | $3,530,998 |
| Edward J. Dulac III | 2020 | $142,500 | $137,917 | $1,420,800 | $3,786,529 | $75,833 | $120,000 | $5,683,579 |
| Bahram Valamehr, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Bahram Valamehr, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Bahram Valamehr, Ph.D. | 2018 | $321,865 | - | - | $2,138,235 | $117,250 | - | $2,577,350 |
| Cindy R. Tahl, J.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Cindy R. Tahl, J.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Cindy R. Tahl, J.D. | 2018 | $350,000 | - | - | $906,465 | $122,500 | - | $1,378,965 |
| Daniel D. Shoemaker, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Daniel D. Shoemaker, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Daniel D. Shoemaker, Ph.D. | 2018 | $365,000 | - | - | $842,338 | $127,750 | - | $1,335,088 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm
What are Fate Therapeutics Inc's Past Insider Trades?
Fate Therapeutics Inc's most recent insider trade came on November 13, 2023 by Cindy Tahl who sold 24,363 units worth $58.47K . In the last 10 years, insiders at Fate Therapeutics Inc have sold an estimated value of $160.98M and bought an estimated value of $205.58M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO, Cindy Tahl, General Counsel and Secretary, and Bahram Valamehr, Chief R&D Officer .
FATE THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||